Aim: To evaluate changes in liver function parameters and risk factors 1 year after
percutaneous radiofrequency ablation (RFA) therapy in patients with hepatocellular …

Objectives: We investigated how radiofrequency ablation (RFA) alone or the combination
with transcatheter arterial embolization (TAE–RFA) for hepatocellular carcinoma (HCC) …

Methods The subjects in this retrospective study comprised 102 patients with HCC who had
undergone RFA therapy and exhibited no recurrence of HCC 12 months thereafter. Serial …

Background Radio-frequency ablation (RFA) has been employed in the treatment of
Barcelona Clinic Liver Cancer (BCLC) early stage hepatocellular carcinoma (HCC) as …

Purpose To evaluate changes in liver function and portal hypertension parameters after
repeated percutaneous radiofrequency (RF) ablation for hepatocellular carcinoma (HCC) in …

BACKGROUND:: Effects of radiofrequency ablation (RFA) on hepatic reserve capacity have
not been evaluated thoroughly thus far. The aim of our study is to evaluate the factors that …

Objective Percutaneous radiofrequency ablation (RFA) is one of the first-line curative
therapies for hepatocellular carcinoma (HCC), but factors affecting the prognosis remain …

Objective: To report on our 20 years' experience on complications after radiofrequency
ablation (RFA) of hepatocellular carcinoma (HCC) in patients with cirrhosis. Methods: From …

Objective To determine the survival outcome and prognostic factors of hepatocellular
carcinoma (HCC) survival in patients who underwent radiofrequency ablation (RFA) …

Background: Whether age plays an important role in the outcomes of HCC after RFA
remains controversial. Study: Two hundred fifty-eight consecutive treatment naive HCC …